Clinical trial
A Study of Lumigan® 0.01% in Patients With Primary Open Angle Glaucoma (POAG) or Ocular Hypertension (OHT)
NCT01589510 is registered in ClinicalTrials.gov with Allergan as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Study of Lumigan® 0.01% in Patients With Primary Open Angle Glaucoma (POAG) or Ocular Hypertension (OHT)
- Lead sponsor
- Allergan
- Phase
- Observational
- Overall status
- Completed
- Start date
- April 30, 2012
- Completion date
- February 28, 2013
- Enrollment
- 419 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.